What if every newborn received a genome sequence alongside the traditional heel prick test? The Economist explores the rapid expansion of genomic newborn screening through England’s Generation Study, BabySeq in the United States, and similar efforts across Australia and Europe, highlighting both the potential to transform early diagnosis and the ethical challenges that accompany its implementation.
